The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 21, 2021

Filed:

Sep. 25, 2015
Applicants:

Nanyang Technological University, Singapore, SG;

National Skin Center (S) Pte Ltd, Singapore, SG;

Inventors:

Sierin Lim, Singapore, SG;

Sathyamoorthy Bhaskar, Singapore, SG;

Steven Thng, Singapore, SG;

Ambili Kuniyil, Singapore, SG;

Sarker Mridul, Singapore, SG;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/34 (2006.01); C07K 14/695 (2006.01); C07K 14/32 (2006.01); C07K 14/685 (2006.01); C07K 14/69 (2006.01); C07K 14/72 (2006.01); C07K 14/47 (2006.01); A61K 9/00 (2006.01); A61K 38/35 (2006.01); C07K 14/195 (2006.01); A61P 17/00 (2006.01); A61K 47/10 (2017.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 38/34 (2013.01); A61K 9/0014 (2013.01); A61K 38/35 (2013.01); A61K 47/10 (2013.01); A61P 17/00 (2018.01); C07K 14/195 (2013.01); C07K 14/32 (2013.01); C07K 14/47 (2013.01); C07K 14/685 (2013.01); C07K 14/69 (2013.01); C07K 14/695 (2013.01); C07K 14/723 (2013.01); B82Y 5/00 (2013.01); C12Y 102/04001 (2013.01);
Abstract

The present invention relates to protein nanocages comprising a melanocyte-targeting moiety and pharmaceutical compositions comprising the protein cages as well as methods for treating or diagnosing hyperpigmentation disorders or other melanocyte-related disorders using the protein nanocages or pharmaceutical compositions. In the preferred embodiment, the protein nanocage is composed ofE2 protein of pyruvate dehydrogenase multi-enzyme complex (E2), with a skin penetrating and cell permeating SPACE moiety, and a melanocyte-targeting moiety of alpha melanocyte stimulating hormone.


Find Patent Forward Citations

Loading…